rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2006-2-7
|
pubmed:abstractText |
Benign prostatic hyperplasia (BPH) is a disease affecting about 25% of men over the age of 40. One half of these men report symptoms that interfere with their daily activities.
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1166-7087
|
pubmed:author |
pubmed-author:AbbouClaudeC,
pubmed-author:BallangerPhilippeP,
pubmed-author:BaronJean-ChristopheJC,
pubmed-author:BuzelinJean-MarieJM,
pubmed-author:CavillonChristopheC,
pubmed-author:ColombelMarcM,
pubmed-author:HaillotOlivierO,
pubmed-author:LambertDidierD,
pubmed-author:LobelBernardB,
pubmed-author:MartinXavierX,
pubmed-author:RichardFrançoisF,
pubmed-author:SarramonJean-PierreJP,
pubmed-author:SaussineChristianC
|
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
674-80
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
|
pubmed:year |
2005
|
pubmed:articleTitle |
[Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate].
|
pubmed:affiliation |
Service d'Urologie, Hôpital Edouard Herriot, Lyon, France. xavier.martin@chu-lyon.fr
|
pubmed:publicationType |
Journal Article,
English Abstract,
Multicenter Study
|